.png){kind=icon}
.png){kind=icon}
Return
Comparative risk of ventricular arrhythmia and sudden cardiac death among acetylcholinesterase inhibitors in dementia: A population-based cohort study
.png){kind=icon}
PRE
AI
H
L
Y
H
L
F
DOI：10.1002/bcp.70656.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Previous studies have suggested that acetylcholinesterase inhibitors (AChEIs) may be associated with an increased risk of ventricular arrhythmia or sudden cardiac death, potentially related to QTc prolongation. However, evidence comparing the real-world risk of severe cardiac conduction outcomes among the three AChEIs—donepezil, galantamine and rivastigmine—remains limited.
Keywords:
acetylcholinesterase inhibitor
Alzheimer's disease
dementia
sudden cardiac death
ventricular arrhythmia
Journal
IF:
3
Papers:
8.5K
Citations:
1.8W
Organization
Cited Papers